What are the major opportunities in the Malignant Pleural Effusion market? What are the strategies for the Malignant Pleural Effusion market?

For detailed insights on the major opportunities and strategies in the Malignant Pleural Effusion market, Read More

How does the Malignant Pleural Effusion market relate to the overall economy and other similar markets?

For detailed insights on Malignant Pleural Effusion's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Malignant Pleural Effusion market growth? SWOT analysis of the Malignant Pleural Effusion market.

For detailed insights on the key dynamics influencing the Malignant Pleural Effusion market growth and SWOT analysis of the Malignant Pleural Effusion industry, Read More

Global Malignant Pleural Effusion Market Report 2025

Item added to cart!

Published : December 2025

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00 $3367.00

Purchase This Report Download Sample PDF

Purchase This Report

Malignant Pleural Effusion Global Market Report 2025

Name: Malignant Pleural Effusion Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Treatment (Systemic Therapy, Therapeutic Thoracentesis, Thoracic Drainage And Pleurodesis, Indwelling Pleural Catheter), By Diagnosis (Pleural Fluid Cytology, Immunohistochemical Tests, Imaging Tests, Pleural Thoracentosis, Pleuroscopy, Pleural Biopsy), By End Users (Hospitals, Ambulatory Clinics, Other End Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Malignant Pleural Effusion Market Overview

• Malignant Pleural Effusion market size has reached to $4.42 billion in 2024

• Expected to grow to $6.12 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%

• Growth Driver: Rising Cases Of Lung Cancer Driving The Growth Of The Market Due To Increasing Treatment Demand

• Market Trend: Focus On Enzyme-Targeting Therapy For Improved Treatment Outcomes

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Malignant Pleural Effusion Market?

Malignant pleural effusion (MPE) refers to the accumulation of fluid in the pleural space due to the presence of cancer cells, typically resulting from metastatic disease. This condition occurs when cancer spreads to the pleura, the thin membrane surrounding the lungs, leading to increased vascular permeability and impaired lymphatic drainage.

The main treatment types for malignant pleural effusion include systemic therapy, therapeutic thoracentesis, thoracic drainage and pleurodesis, and indwelling pleural catheter placement. Systemic therapy is a cancer treatment that circulates through the bloodstream to target and eliminate cancer cells throughout the body. This is diagnosed using various methods, such as pleural fluid cytology, immunohistochemical tests, imaging tests, pleural thoracentesis, pleuroscopy, and pleural biopsy. These treatments and diagnostic methods are utilized by various end users, including hospitals, ambulatory clinics, and other healthcare facilities.

Malignant Pleural Effusion Market Size and growth rate 2025 to 2029: Graph

What Is The Malignant Pleural Effusion Market Size 2025 And Growth Rate?

What Is The Malignant Pleural Effusion Market Growth Forecast?

The malignant pleural effusion market size is expected to see strong growth in the next few years. It will grow to $6.12 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to increasing healthcare infrastructure, rising government support, increasing cancer survivors, rising demand for home-based care, growth in liquid biopsy. Major trends in the forecast period include the integration of artificial intelligence in imaging tools, advancements in targeted cancer therapies, advancements in pleurodesis, improvements in biomarkers, and expanding clinical trials for novel therapeutic agents.

The forecast of 6.7% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of pleurodesis agents and indwelling pleural catheters sourced from the UK and Japan, thereby delaying palliative care interventions and elevating thoracic oncology expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Malignant Pleural Effusion Market Segmented?

1) By Treatment: Systemic Therapy, Therapeutic Thoracentesis, Thoracic Drainage And Pleurodesis, Indwelling Pleural Catheter

2) By Diagnosis: Pleural Fluid Cytology, Immunohistochemical Tests, Imaging Tests, Pleural Thoracentosis, Pleuroscopy, Pleural Biopsy

3) By End Users: Hospitals, Ambulatory Clinics, Other End Users

Subsegmentss:

1) By Systemic Therapy: chemotherapy, targeted therapy, Immunotherapy

2) By Therapeutic Thoracentesis: Single-Time Thoracentesis, Repeated Thoracentesis

3) By Thoracic Drainage And Pleurodesis:Chemical Pleurodesis, Mechanical Pleurodesis, Biological Pleurodesis

4) By Indwelling Pleural Catheter:Tunneled Pleural Catheter, Non-Tunneled Pleural Catheter

What Is Driving The Malignant Pleural Effusion Market? Rising Cases Of Lung Cancer Driving The Growth Of The Market Due To Increasing Treatment Demand

The rising cases of lung cancer is expected to propel the growth of the malignant pleural effusion market going forward. Lung cancer is a disease characterized by the uncontrolled growth of abnormal cells in the lungs, which can form tumors and interfere with normal lung function. The rising cases of lung cancer are due to smoking and tobacco use, as prolonged exposure to harmful chemicals in cigarettes damages lung tissues, triggers genetic mutations, and promotes the uncontrolled growth of cancerous cells, significantly increasing the likelihood of developing the disease. Malignant pleural effusion indicates advanced lung cancer progression by facilitating tumor spread within the pleural cavity, leading to worsened respiratory function and a poorer prognosis. For instance, in January 2023, according to the American Cancer Society Facts and Figures, a US-based professional organizations company, the estimated number of new lung and bronchus cancer cases was 236,740 in 2022 and 238,340 in 2023, while the estimated deaths were 130,180 in 2022 and 127,070 in 2023. Therefore, the rising cases of lung cancer is driving the growth of the malignant pleural effusion industry.

What Is Driving The Malignant Pleural Effusion Market? Impact Of Improving Healthcare Infrastructure On The Market Due To Enhanced Diagnosis And Treatment Accessibility

The improving healthcare infrastructure is expected to propel the growth of the malignant pleural effusion market going forward. Healthcare infrastructure refers to the physical, technological, and organizational structures required for delivering healthcare services, including hospitals, clinics, medical equipment, IT systems, and workforce. Improving healthcare infrastructure is attributed to need for better disease management, all of which contribute to enhanced healthcare accessibility, efficiency, and quality of care. Improving healthcare infrastructure enhances the diagnosis, treatment, and management of malignant pleural effusion by enabling access to advanced medical technologies, better-equipped healthcare facilities, and specialized care, ultimately improving patient outcomes. For instance, in May 2023, according to the American Health Care Association, a US-based nonprofit organization, the number of hospitals in the United States increased by 0.591% from the previous year, rising from 6,093 to 6,129. Therefore, the improving healthcare infrastructure is driving the growth of the malignant pleural effusion industry.

Who Are The Major Players In The Global Malignant Pleural Effusion Market?

Major companies operating in the malignant pleural effusion market are Pfizer Inc., Merck & Co. Inc., Novartis International AG, Bristol-Myers Squibb Company, Gilead Sciences Inc., Amgen Inc., Medline Industries LP, Becton Dickinson and Company, Cook Medical LLC, Merit Medical Systems Inc., Argon Medical Devices Inc., B Braun SE, Simcere Pharmaceutical Group Limited, pfm medical AG, Redax SpA, Wuhan YZY Biopharma Co. Ltd., Rocket Medical plc, Genelux Corporation, Gongwin Biopharm Holdings Co. Ltd., Ewimed GmbH

What Are The Key Trends Of The Global Malignant Pleural Effusion Market? Focus On Enzyme-Targeting Therapy For Improved Treatment Outcomes

Major companies operating in the malignant pleural effusion market are focusing on developing innovative therapies such as enzyme-targeting therapy to improve treatment outcomes by targeting specific enzymes involved in fluid accumulation. Enzyme-targeting therapy is a medical approach that involves designing drugs or treatments to specifically inhibit or modify the activity of enzymes associated with diseases. This therapy is commonly used in conditions such as cancer, metabolic disorders, and infectious diseases, where abnormal enzyme activity contributes to disease progression. For instance, in September 2022, RS Oncology, LLC, a US-based biotechnology company, Initiated the MITOPE clinical trial, a first-in-human Phase 1/2 trial conducted in the United Kingdom. This study is a Phase 1/2 trial assessing RSO-021, a novel PRX3 inhibitor designed to treat malignant pleural effusion and mesothelioma by targeting oxidative stress to eliminate cancer cells while preserving healthy tissue.

Need data on a specific region in this market?

Request Regional Data

What Is The Regional Outlook For The Global Malignant Pleural Effusion Market?

North America was the largest region in the malignant pleural effusion market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Malignant Pleural Effusion Market?

The malignant pleural effusion market consists of revenues earned by entities by providing services such as biopsy and cytology testing, chemotherapy and targeted therapy, and pleurodesis. The market value includes the value of related goods sold by the service provider or included within the service offering. The malignant pleural effusion market also includes sales of chest drainage systems, pleural access kits, and imaging-guided drainage equipment, and thoracentesis devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Malignant Pleural Effusion Industry?

The malignant pleural effusion market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the malignant pleural effusion industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Malignant Pleural Effusion Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$4.73 billion
Revenue Forecast In 2034	$6.12 billion
Growth Rate	CAGR of 6.7% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The malignant pleural effusion market covered in this report is segmented – 1) By Treatment: Systemic Therapy, Therapeutic Thoracentesis, Thoracic Drainage And Pleurodesis, Indwelling Pleural Catheter 2) By Diagnosis: Pleural Fluid Cytology, Immunohistochemical Tests, Imaging Tests, Pleural Thoracentosis, Pleuroscopy, Pleural Biopsy 3) By End Users: Hospitals, Ambulatory Clinics, Other End Users Subsegmentss: 1) By Systemic Therapy: Chemotherapy, Targeted Therapy, Immunotherapy 2) By Therapeutic Thoracentesis: Single-Time Thoracentesis, Repeated Thoracentesis 3) By Thoracic Drainage And Pleurodesis:Chemical Pleurodesis, Mechanical Pleurodesis, Biological Pleurodesis 4) By Indwelling Pleural Catheter:Tunneled Pleural Catheter, Non-Tunneled Pleural Catheter
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., Merck & Co. Inc., Novartis International AG, Bristol-Myers Squibb Company, Gilead Sciences Inc., Amgen Inc., Medline Industries LP, Becton Dickinson and Company, Cook Medical LLC, Merit Medical Systems Inc., Argon Medical Devices Inc., B Braun SE, Simcere Pharmaceutical Group Limited, pfm medical AG, Redax SpA, Wuhan YZY Biopharma Co. Ltd., Rocket Medical plc, Genelux Corporation, Gongwin Biopharm Holdings Co. Ltd., Ewimed GmbH
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Malignant Pleural Effusion Market Characteristics

3. Malignant Pleural Effusion Market Trends And Strategies

4. Malignant Pleural Effusion Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Malignant Pleural Effusion Growth Analysis And Strategic Analysis Framework

5.1. Global Malignant Pleural Effusion PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Malignant Pleural Effusion Market Growth Rate Analysis

5.4. Global Malignant Pleural Effusion Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Malignant Pleural Effusion Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Malignant Pleural Effusion Total Addressable Market (TAM)

6. Malignant Pleural Effusion Market Segmentation

6.1. Global Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Systemic Therapy

Therapeutic Thoracentesis

Thoracic Drainage And Pleurodesis

Indwelling Pleural Catheter

6.2. Global Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pleural Fluid Cytology

Immunohistochemical Tests

Imaging Tests

Pleural Thoracentosis

Pleuroscopy

Pleural Biopsy

6.3. Global Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Ambulatory Clinics

Other End Users

6.4. Global Malignant Pleural Effusion Market, Sub-Segmentation Of Systemic Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Chemotherapy

Targeted Therapy

Immunotherapy

6.5. Global Malignant Pleural Effusion Market, Sub-Segmentation Of Therapeutic Thoracentesis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Single-Time Thoracentesis

Repeated Thoracentesis

6.6. Global Malignant Pleural Effusion Market, Sub-Segmentation Of Thoracic Drainage And Pleurodesis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Chemical Pleurodesis

Mechanical Pleurodesis

Biological Pleurodesis

6.7. Global Malignant Pleural Effusion Market, Sub-Segmentation Of Indwelling Pleural Catheter, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Tunneled Pleural Catheter

Non-Tunneled Pleural Catheter

7. Malignant Pleural Effusion Market Regional And Country Analysis

7.1. Global Malignant Pleural Effusion Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Malignant Pleural Effusion Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Malignant Pleural Effusion Market

8.1. Asia-Pacific Malignant Pleural Effusion Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Malignant Pleural Effusion Market

9.1. China Malignant Pleural Effusion Market Overview

9.2. China Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Malignant Pleural Effusion Market

10.1. India Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Malignant Pleural Effusion Market

11.1. Japan Malignant Pleural Effusion Market Overview

11.2. Japan Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Malignant Pleural Effusion Market

12.1. Australia Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Malignant Pleural Effusion Market

13.1. Indonesia Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Malignant Pleural Effusion Market

14.1. South Korea Malignant Pleural Effusion Market Overview

14.2. South Korea Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Malignant Pleural Effusion Market

15.1. Western Europe Malignant Pleural Effusion Market Overview

15.2. Western Europe Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Malignant Pleural Effusion Market

16.1. UK Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Malignant Pleural Effusion Market

17.1. Germany Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Malignant Pleural Effusion Market

18.1. France Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Malignant Pleural Effusion Market

19.1. Italy Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Malignant Pleural Effusion Market

20.1. Spain Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Malignant Pleural Effusion Market

21.1. Eastern Europe Malignant Pleural Effusion Market Overview

21.2. Eastern Europe Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Malignant Pleural Effusion Market

22.1. Russia Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Malignant Pleural Effusion Market

23.1. North America Malignant Pleural Effusion Market Overview

23.2. North America Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Malignant Pleural Effusion Market

24.1. USA Malignant Pleural Effusion Market Overview

24.2. USA Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Malignant Pleural Effusion Market

25.1. Canada Malignant Pleural Effusion Market Overview

25.2. Canada Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Malignant Pleural Effusion Market

26.1. South America Malignant Pleural Effusion Market Overview

26.2. South America Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Malignant Pleural Effusion Market

27.1. Brazil Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Malignant Pleural Effusion Market

28.1. Middle East Malignant Pleural Effusion Market Overview

28.2. Middle East Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Malignant Pleural Effusion Market

29.1. Africa Malignant Pleural Effusion Market Overview

29.2. Africa Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Malignant Pleural Effusion Market Competitive Landscape And Company Profiles

30.1. Malignant Pleural Effusion Market Competitive Landscape

30.2. Malignant Pleural Effusion Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Malignant Pleural Effusion Market Other Major And Innovative Companies

31.1. Amgen Inc.

31.2. Medline Industries LP

31.3. Becton Dickinson and Company

31.4. Cook Medical LLC

31.5. Merit Medical Systems Inc.

31.6. Argon Medical Devices Inc.

31.7. B Braun SE

31.8. Simcere Pharmaceutical Group Limited

31.9. pfm medical AG

31.10. Redax SpA

31.11. Wuhan YZY Biopharma Co. Ltd.

31.12. Rocket Medical plc

31.13. Genelux Corporation

31.14. Gongwin Biopharm Holdings Co. Ltd.

31.15. Ewimed GmbH

32. Global Malignant Pleural Effusion Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Malignant Pleural Effusion Market

34. Recent Developments In The Malignant Pleural Effusion Market

35. Malignant Pleural Effusion Market High Potential Countries, Segments and Strategies

35.1 Malignant Pleural Effusion Market In 2029 - Countries Offering Most New Opportunities

35.2 Malignant Pleural Effusion Market In 2029 - Segments Offering Most New Opportunities

35.3 Malignant Pleural Effusion Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Malignant Pleural Effusion Market, Sub-Segmentation Of Systemic Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Malignant Pleural Effusion Market, Sub-Segmentation Of Therapeutic Thoracentesis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Malignant Pleural Effusion Market, Sub-Segmentation Of Thoracic Drainage And Pleurodesis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Malignant Pleural Effusion Market, Sub-Segmentation Of Indwelling Pleural Catheter, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Malignant Pleural Effusion Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Malignant Pleural Effusion Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Pfizer Inc. Financial Performance

Table 79: Merck & Co. Inc. Financial Performance

Table 80: Novartis International AG Financial Performance

Table 81: Bristol-Myers Squibb Company Financial Performance

Table 82: Gilead Sciences Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Malignant Pleural Effusion Market, Sub-Segmentation Of Systemic Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Malignant Pleural Effusion Market, Sub-Segmentation Of Therapeutic Thoracentesis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Malignant Pleural Effusion Market, Sub-Segmentation Of Thoracic Drainage And Pleurodesis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Malignant Pleural Effusion Market, Sub-Segmentation Of Indwelling Pleural Catheter, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Malignant Pleural Effusion Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Malignant Pleural Effusion Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Pfizer Inc. Financial Performance

Figure 79: Merck & Co. Inc. Financial Performance

Figure 80: Novartis International AG Financial Performance

Figure 81: Bristol-Myers Squibb Company Financial Performance

Figure 82: Gilead Sciences Inc. Financial Performance

Intestinal Fistula Treatment Market Overview 2025: Competitive Shifts, Forecast Models, and Emerging Opportunities

Next-Gen Invasive Aspergillosis Therapeutics : Market Forecast, Transformation, and Long-Term Trajectories

Iron Deficiency Anemia Growth Trajectory: Key Forecasts and Strategic Insights

Lewy Body Dementia Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Pulmonary Embolism Global Market Report 2025 – By Treatment (Medications, Mechanical Devices, Other Treatments), By Diagnosis (Chest X-Ray, Electrocardiogram (ECG), Magnetic Resonance Imaging (MRI), Computed Tomography S...

Esophageal Cancer Global Market Report 2025 – By Type (Esophageal Squamous-Cell Carcinoma, Esophageal Adenocarcinoma, Other Types), By Treatment Type (Chemotherapy, Targeted Therapy, Other Treatment Types), By Route Of A...

Aortic Aneurysm Global Market Report 2025 – By Type (Thoracic Aortic Aneurysm (TAA), Abdominal Aortic Aneurysm (AAA)), By Treatment (Open Surgical Repair (OSR), Endovascular Aneurysm Repair (EVAR)), By End User (Hospital...

Non-Small Cell Lung Cancer (NSCLC) Global Market Report 2025 – By Type (Squamous Cell Carcinoma, Large Cell Carcinoma, Adenocarcinoma, Other Types), By Therapy (Radiotherapy, Laserthearpy, Photodynamic Therapy (PDT), Oth...

Embolization Coils Global Market Report 2025 – By Type (Detachable Coil, Pushable Coil), By Material (Platinum, Platinum And Hydrogel, Platinum Tungsten Alloy), By Application (Neurology, Urology, Peripheral Vascular Dis...

Tumor Ablation Global Market Report 2025 – By Type (Thermal Ablation, Chemical Ablation), By Types Of Treatment (Percutaneous, Laparoscopic, Surgical), By Application (Kidney Cancer, Liver Cancer, Breast Cancer, Lung Can...

Interstitial Lung Disease Global Market Report 2025 – By Drug Type (Oral Corticosteroids, Immune Suppressing, Anti-Fibrotic Medication, Other Drugs), By Disease Type (Interstitial Pneumonia, Idiopathic Pulmonary Fibrosis...

Frequently Asked Questions

What is the definition of the Malignant Pleural Effusion market?

How will the Malignant Pleural Effusion market drivers and restraints affect the market dynamics? What forces will shape the Malignant Pleural Effusion industry going forward?

The market major growth driver - Rising Cases Of Lung Cancer Driving The Growth Of The Market Due To Increasing Treatment Demand. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Malignant Pleural Effusion market?

The malignant pleural effusion market size has grown strongly in recent years. It will grow from $4.42 billion in 2024 to $4.73 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to the growing adoption of indwelling pleural catheters, increased focus on palliative allative care, increasing clinical trials, rising reimbursement, and rising metastatic malignancies. The malignant pleural effusion market size is expected to see strong growth in the next few years. It will grow to " $6.12 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to increasing healthcare infrastructure, rising government support, increasing cancer survivors, rising demand for home-based care, growth in liquid biopsy. Major trends in the forecast period include the integration of artificial intelligence in imaging tools, advancements in targeted cancer therapies, advancements in pleurodesis, improvements in biomarkers, and expanding clinical trials for novel therapeutic agents. For further insights on this market, request a sample here

How is the Malignant Pleural Effusion market segmented?

The malignant pleural effusionmarket covered in this report is segmented –
1) By Treatment: Systemic Therapy; Therapeutic Thoracentesis; Thoracic Drainage And Pleurodesis; Indwelling Pleural Catheter
2) By Diagnosis: Pleural Fluid Cytology; Immunohistochemical Tests; Imaging Tests; Pleural Thoracentosis; Pleuroscopy; Pleural Biopsy
3) By End Users: Hospitals; Ambulatory Clinics; Other End Users Subsegments:
1) By Systemic Therapy: Chemotherapy; Targeted Therapy; Immunotherapy
2) By Therapeutic Thoracentesis: Single-Time Thoracentesis; Repeated Thoracentesis
3) By Thoracic Drainage And Pleurodesis:Chemical Pleurodesis; Mechanical Pleurodesis; Biological Pleurodesis
4) By Indwelling Pleural Catheter:Tunneled Pleural Catheter; Non-Tunneled Pleural Catheter For further insights on this market, request a sample here

Which region has the largest share of the Malignant Pleural Effusion market? What are the other regions covered in the report?

North America was the largest region in the malignant pleural effusion market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the malignant pleural effusion market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Malignant Pleural Effusion market?

What are the key trends in the Malignant Pleural Effusion market?

Major trends in this market include Focus On Enzyme-Targeting Therapy For Improved Treatment Outcomes. For further insights on this market, request a sample here.